Sucampo Pharmaceuticals Inc. (SCMP)
Symbol Info
Listed Symbol SCMP
Name Sucampo Pharmaceuticals Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2016-12-31
Latest Fiscal Revenue $230,056,000
Latest Fiscal EPS $0.42
Price Info
21 Day Moving Average $17.9643
21 Day EMA $17.883830
50 Day Moving Average $17.3430
50 Day EMA $16.795250
200 Day EMA $13.564850
200 Day Moving Average 12.375880
52 Week High $18.75
52 Week Low $9.30
52 Week Change $56.521700
Alpha 0.022046
Beta 1.2852
Standard Deviation 0.172154
R2 0.046344
Periods 60
Share Information
10 Day Average Volume 1,589,110
20 Day Average Volume 1,984,179
30 Day Average Volume 2,557,383
50 Day Average Volume 3,292,798
Outstanding Shares 47,168,505
Float Shares 46,918,439
Percent Float 99.47%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 230
Institute Holdings Date 2017-12-31
Institute Bought Previous 3 Months 2,656,721
Institute Holdings Percent 91.700000
Institute Sold Previous 3 Months 2,203,864
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 250,066
Price Change
7 Day Price Change $0.0499992
7 Day Percent Change 0.28%
21 Day Price Change $0.0499992
21 Day Percent Change 0.28%
30 Day Price Change $-0.0499992
30 Day Percent Change -0.28%
Month To Date Price Change $0.0500
Month To Date Percent 0.28%
90 Day Price Change $7.700000
90 Day Percent Change 74.76%
Quarter To Date $0.049999
Quarter To Date Percent 0.28%
180 Day Price Change $7.750000
180 Day Percent Change 75.61%
200 Day Price Change $7.150000
200 Day Percent Change 65.90%
Year To Date $0.049999
Year To Date Percent 0.28%
Profile
Description Sucampo Pharmaceuticals Inc is a part of the healthcare sector in the United States. As a global pharmaceutical company, it commercializes drugs for the treatment of various gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It currently generates revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development activities.
Details
Issue Type CS
Market Cap $849,033,090
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding -
CEO Peter S. Greenleaf
Employees 139
Last Audit UQ
Classification
CIK 0001365216
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 805 King Farm Boulevard
Suite 550
Rockville, MD 20850
Website http://www.sucampo.com
Facisimile +1 301 961-3440
Telephone +1 301 961-3400
Email investor@sucampo.com
Key Ratios
Profitability
EBIT Margin -52.8
EBITDA Margin -40.7
Pre-Tax Profit Margin 15.2
Profit Margin Cont -93.65
Gross Margin 72.80
Profit Margin TOT -93.65
Income Statements
Revenue $177,445,000
Revenue Per Share $3.7619
Revenue 3 Years $19.21
Revenue 5 Years $21.91
Valuation Measures
PE Ratio -
Enterprise Value $1,067,531,090
Price To Sales 4.784768
Price To Free Cash 16.800000
PE High Last 5 Years -
Price To Book 21.4
Price To Cash Flow 28.6
PE Low Last 5 Years -
Price To Tangible Book -6
Financial Strength
Total Debt To Equity 7.4
Int Coverage -9.2
Current Ratio 5.1
Leverage Ratio 5.2
Quick Ratio 3.5
Long Term Debt To Capital 0.88
Assets
Receivables Turnover 2.7
Invoice Turnover 2.70
Assets Turnover 0.40
Management Effectiveness
Return Assets -34.76
Return On Equity -158.1
Return On Capital -40.59
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
SCMP
Sucampo Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.